3 Adoption of means to political ends which show disregard for the life, liberty, and human rights of others.

Imanova is now part of Invicro. Combined business delivers world leading. Drug development is a time consuming, complex, risky and expensive venture. There is an increasing requirement to find ways to accelerate and reduce the cost of decision making so that only the best candidate molecules progress to the later stages of drug development. Since inception, Imanova has completed over 93 clinical studies and has successfully developed and-or implemented over 30 radioligands for pre-clinical and clinical u.